A Bridging Study of Efsubaglutide Alfa in Healthy Adults in Brazil
Clinical trial NCT07518121 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07518121
- Sponsor
- Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2026-08-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.